Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions
Fresh off the heels of a disappointing trial for one experimental drug, the company has just reported results for another drug that might be its best candidate yet
Animal studies from a Croatian research group attribute its effects to angiogenesis and fibroblast activity in healing tendons, ligaments, and muscle tissue, not to building new muscle protein
The effect of GLP-1R agonists liraglutide and exendin-4 was examined in vitro on LOVO, CA-77, MCF-7, MDA-MB-231, KPL-1, MB-468, 4TI, BT483, ZR751, LNCap, PC3, ALVA-41, DU145, LNCap, PANC-1, MiaPaCa-2, PANC, CT26, SKOV3, OVCAR3, OVCAR4, A2780, and ES-2 cell lines that are expressed in several cancers including colorectal, pancreatic, thyroid, breast, prostate, ovarian, and colon (Table 1)